A prospective, single-center, phase II randomized controlled trial to evaluate the safety, feasibility, and preliminary efficacy of exercise during intravesical therapy for nonmuscle invasive bladder cancer.

被引：0
|
作者：
Arthuso, Fernanda Z. [1 ]
Fairey, Adrian S. [1 ]
Boule, Normand G. [1 ]
Courneya, Kerry S. [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.TPS600
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS600
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guerin Instillation Therapy for Nonmuscle Invasive Bladder Cancer
    Yokomizo, Akira
    Kanimoto, Yusuke
    Okamura, Takehiko
    Ozono, Seiichiro
    Koga, Hirofumi
    Iwamura, Masatsugu
    Tanaka, Hiroshi
    Takahashi, Satoru
    Tsushima, Tomoyasu
    Kanayama, Hiro-omi
    Akaza, Hideyuki
    Shinohara, Nobuo
    Mugiya, Soichi
    Nomata, Koichiro
    Nakamura, Tsuyoshi
    Naito, Seiji
    JOURNAL OF UROLOGY, 2016, 195 (01): : 41 - 46
  • [22] Efficacy and safety of disitamab vedotin combined with gemcitabine as neoadjuvant therapy for muscle-invasive bladder cancer: A multi-center, single-arm, phase II trial
    Yang, C.
    Huang, H.
    Zeng, X.
    Dai, H.
    Zhou, G.
    Wang, S.
    Hu, Z.
    ANNALS OF ONCOLOGY, 2024, 35 : S1148 - S1148
  • [23] FEASIBILITY, SAFETY AND EFFICACY OF ENDOSCOPIC GASTROPLASTY FOR TREATMENT OF OBESE PATIENTS: PRELIMINARY RESULTS AT 6 MONTHS FOLLOW-UP FROM A PROSPECTIVE, SINGLE CENTER, RANDOMIZED CONTROLLED TRIAL
    Di Prampero, Vadala S. F.
    Rocchi, C.
    Massidda, M.
    Milano, V.
    Sula, V.
    Addis, F.
    Bazzu, P.
    Cosseddu, V.
    Masia, S.
    Di Maio, F.
    Giustacchini, P.
    Bulajic, M.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S181 - S181
  • [24] A RANDOMIZED, OPEN-LABEL, SINGLE-CENTER, PHASE II CLINICAL TRIAL TO EXPLORE THE SAFETY AND EFFICACY OF RECOMBINANT HEPATITIS B IMMUNOGLOBULIN
    Song, Gi-Won
    Lee, Sung-Gyu
    Hwang, Shin
    Park, Gil-Chun
    Chung, Yongkyu
    Ha, Su-Min
    Kang, Sang-Hyun
    Lee, Hyoung Uk
    Lee, Yun Hee
    Kwon, Jae-Hyun
    Jwa, Eun-Kyung
    Cho, Hwui-Dong
    TRANSPLANT INTERNATIONAL, 2017, 30 : 231 - 231
  • [25] Efficacy and Safety of the Remimazolam-Alfentanil Combination for Sedation During Gastroscopy: A Randomized, Double-blind, Single-center Controlled Trial
    Shi, Wenyan
    Cheng, Yi
    He, Hongying
    Fang, Qiang
    Hu, Yi
    Xu, Xinpeng
    Shuai, Yu
    Zhang, Jie
    Fang, Xingguo
    Wang, Zhao
    Zhang, Yi
    CLINICAL THERAPEUTICS, 2022, 44 (11) : 1506 - 1518
  • [26] Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial
    Cheng, Jianping
    Fan, Chanjuan
    Huang, Kun
    Zhai, Lili
    Wang, Hui
    Xie, Dongling
    Cai, Yong
    Li, Zhen
    Bai, Qixuan
    Wang, Pan
    Ding, Haiou
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [27] Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial
    Wang, Leiping
    Cao, Jun
    Li, Chunlei
    Wang, Xiaodong
    Zhao, Yannan
    Li, Ting
    Du, Yiqun
    Tao, Zhonghua
    Peng, Wenxia
    Wang, Biyun
    Zhang, Jian
    Zhang, Sheng
    Wang, Zhonghua
    Hu, Xichun
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (02) : 330 - 339
  • [28] Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial
    Leiping Wang
    Jun Cao
    Chunlei Li
    Xiaodong Wang
    Yannan Zhao
    Ting Li
    Yiqun Du
    Zhonghua Tao
    Wenxia Peng
    Biyun Wang
    Jian Zhang
    Sheng Zhang
    Zhonghua Wang
    Xichun Hu
    Investigational New Drugs, 2022, 40 : 330 - 339
  • [29] Efficacy and safety of liposomal mitoxantrone (Lipo-MIT) in advanced breast cancer (ABC): A randomized, open label, active-controlled, single-center, phase II clinical trial.
    Wang, Leiping
    Zhao, Yannan
    Li, Ting
    Cao, Jun
    Du, Yiqun
    Tao, Zhonghua
    Peng, Wenxia
    Wang, Biyun
    Zhang, Jian
    Wang, Zhonghua
    Huan, Xiulin
    Dou, Jing
    Hao, Chunyan
    Li, Xiaojing
    Wang, Xiaodong
    Meng, Zhibin
    Lv, Yanan
    Gao, Cuixia
    Hu, Xi-Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Efficacy and safety of vonoprazan-amoxicillin dual therapy for Helicobacter pylori first-line treatment: a single-center, randomized, controlled trial
    Wang, Xiaolei
    Teng, Guigen
    Dong, Xinhong
    Dai, Yun
    Wang, Weihong
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
12345